연구성과로 돌아가기
JCR 2023 저널 목록 (784 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Artificial Cells Nanomedicine and Biotechnology | TAYLOR & FRANCIS LTD | 2169-1401 | 2169-141X | SCIE | MATERIALS SCIENCE, BIOMATERIALS | 8,664 | 4.5 | Q2 | 40.6 | 59.4 | 22/53 | 5.1 | Q2 | 4.4 | 0.6 | 1.03 | 12/53 | Q1 | 78.30 | 0.008 | 1.660 | 0.728 | Q2 | 53 | 90.6% | 5.3 | 6.3 | 48 | 98.6% | 2025-03-24 17:25:39 | 바로가기 |
| Clinical Proteomics | BMC | 1542-6416 | 1559-0275 | SCIE | BIOCHEMICAL RESEARCH METHODS | 1,268 | 2.8 | Q2 | 40.6 | 59.4 | 35/85 | 3.9 | Q2 | 2.7 | 0.4 | 0.80 | 29/85 | Q2 | 66.47 | 0.002 | 0.360 | 0.990 | Q2 | 52 | 90.4% | 4.8 | 7.2 | 47 | 99.2% | 2025-03-24 16:55:27 | 바로가기 |
| CLINICAL TRANSPLANTATION | WILEY | 0902-0063 | 1399-0012 | SCIE | SURGERY | 6,731 | 1.9 | Q2 | 40.6 | 59.4 | 119/292 | 2.6 | Q2 | 1.8 | 0.4 | 0.73 | 125/292 | Q2 | 57.36 | 0.012 | 2.574 | 1.029 | Q1 | 291 | 90.0% | 5.5 | 7.1 | 262 | 16.1% | 2025-03-24 18:12:58 | 바로가기 |
| DNA REPAIR | ELSEVIER | 1568-7864 | 1568-7856 | SCIE | GENETICS & HEREDITY | 5,925 | 3.0 | Q2 | 40.6 | 59.4 | 78/191 | 3.7 | Q2 | 2.9 | 0.6 | 0.83 | 66/191 | Q2 | 65.71 | 0.008 | 1.686 | 1.535 | Q1 | 84 | 97.6% | 7.8 | 9.0 | 82 | 24.8% | 2025-03-24 17:15:14 | 바로가기 |
| Ecosystems and People | TAYLOR & FRANCIS LTD | N/A | 2639-5916 | ESCI | ENVIRONMENTAL SCIENCES | 710 | 3.5 | Q2 | 40.6 | 59.4 | 146/358 | 4.8 | Q2 | 2.8 | 1.0 | 0.97 | 88/359 | Q1 | 75.63 | 0.001 | 0.290 | 1.156 | Q1 | 50 | 92.0% | 3.0 | 6.9 | 46 | 98.5% | 2025-03-24 17:13:10 | 바로가기 |
| Environmental Science-Advances | ROYAL SOC CHEMISTRY | N/A | 2754-7000 | ESCI | ENVIRONMENTAL SCIENCES | 365 | 3.5 | Q2 | 40.6 | 59.4 | 146/358 | 3.5 | Q2 | 3.3 | 1.0 | 0.55 | 209/359 | Q3 | 41.92 | 0.000 | 0.060 | 0.537 | Q3 | 148 | 83.1% | 1.1 | 6.0 | 123 | 98.6% | 2025-03-24 17:13:14 | 바로가기 |
| Environmental Science-Water Research & Technology | ROYAL SOC CHEMISTRY | 2053-1400 | 2053-1419 | SCIE | ENVIRONMENTAL SCIENCES | 6,316 | 3.5 | Q2 | 40.6 | 59.4 | 146/358 | 4.5 | Q2 | 3.4 | 0.7 | 0.68 | 160/359 | Q2 | 55.57 | 0.009 | 1.945 | 1.001 | Q2 | 250 | 90.4% | 3.9 | 6.1 | 226 | 15.6% | 2025-03-24 17:12:50 | 바로가기 |
| Environments | MDPI | N/A | 2076-3298 | ESCI | ENVIRONMENTAL SCIENCES | 2,918 | 3.5 | Q2 | 40.6 | 59.4 | 146/358 | 3.5 | Q2 | 3.4 | 0.8 | 0.60 | 188/359 | Q3 | 47.77 | 0.003 | 0.684 | 0.587 | Q3 | 222 | 79.7% | 3.7 | 6.9 | 177 | 99.0% | 2025-03-24 17:12:58 | 바로가기 |
| Epigenomics | FUTURE MEDICINE LTD | 1750-1911 | 1750-192X | SCIE | GENETICS & HEREDITY | 3,707 | 3.0 | Q2 | 40.6 | 59.4 | 78/191 | 3.4 | Q2 | 2.8 | 0.6 | 0.72 | 89/191 | Q2 | 53.66 | 0.004 | 0.827 | 0.825 | Q2 | 93 | 61.3% | 5.7 | 5.6 | 57 | 21.2% | 2025-03-24 17:15:17 | 바로가기 |
| Facial Plastic Surgery Clinics of North America | W B SAUNDERS CO-ELSEVIER INC | 1064-7406 | 1558-1926 | SCIE | SURGERY | 1,663 | 1.9 | Q2 | 40.6 | 59.4 | 119/292 | 2.5 | Q2 | 1.8 | 0.1 | 0.78 | 117/292 | Q2 | 60.10 | 0.002 | 0.349 | 0.730 | Q2 | 54 | 96.3% | 7.1 | 9.3 | 52 | 0.0% | 2025-03-24 18:13:09 | 바로가기 |
| FISH & SHELLFISH IMMUNOLOGY | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD | 1050-4648 | 1095-9947 | SCIE | IMMUNOLOGY | 30,271 | 4.1 | Q2 | 40.6 | 59.4 | 74/181 | 4.2 | Q2 | 3.4 | 1.0 | 1.56 | 21/181 | Q1 | 88.67 | 0.018 | 3.914 | 0.604 | Q3 | 688 | 99.8% | 5.8 | 7.6 | 687 | 4.5% | 2025-03-24 17:20:08 | 바로가기 |
| Human Vaccines & Immunotherapeutics | TAYLOR & FRANCIS INC | 2164-5515 | 2164-554X | SCIE | IMMUNOLOGY | 14,390 | 4.1 | Q2 | 40.6 | 59.4 | 74/181 | 4.2 | Q2 | 3.7 | 0.9 | 0.85 | 57/181 | Q2 | 68.78 | 0.018 | 4.046 | 1.014 | Q2 | 452 | 80.8% | 4.1 | 3.8 | 365 | 81.0% | 2025-03-24 17:20:10 | 바로가기 |
| Immunotherapy Advances | OXFORD UNIV PRESS | N/A | 2732-4303 | ESCI | IMMUNOLOGY | 219 | 4.1 | Q2 | 40.6 | 59.4 | 74/181 | 4.1 | Q2 | 4.0 | 0.3 | 0.46 | 132/181 | Q3 | 27.35 | 0.001 | 0.120 | 1.291 | Q2 | 22 | 50.0% | 2.1 | 6.7 | 11 | 94.5% | 2025-03-24 17:20:25 | 바로가기 |
| International Journal of Sediment Research | KEAI PUBLISHING LTD | 1001-6279 | 1001-6279 | SCIE | ENVIRONMENTAL SCIENCES | 2,098 | 3.5 | Q2 | 40.6 | 59.4 | 146/358 | 3.1 | Q3 | 3.4 | 1.0 | 0.84 | 109/359 | Q2 | 69.78 | 0.002 | 0.356 | 0.604 | Q3 | 49 | 95.9% | 5.9 | 11.5 | 47 | 0.0% | 2025-03-24 17:13:01 | 바로가기 |
| Joint Diseases and Related Surgery | TURKISH JOINT DISEASES FOUNDATION | N/A | 2687-4792 | SCIE | SURGERY | 793 | 1.9 | Q2 | 40.6 | 59.4 | 119/292 | 1.5 | Q3 | 1.0 | 0.5 | 0.74 | 123/292 | Q2 | 58.05 | 0.001 | 0.185 | 0.253 | Q4 | 97 | 94.8% | 2.7 | 8.6 | 92 | 89.5% | 2025-03-24 18:13:17 | 바로가기 |
페이지 이동: